Home » Healthcare » Biologic Excipients Market

Biologic Excipients Market By Product Type (Organic, Inorganic, and Others) By Excipient Type (Polymers, Sugar Alcohols, Polysorbates, Inorganic Salts, Amino Acids, Surfactants, and Others) By Functionality (Fillers & diluents, Suspending & viscosity agents, Coating agents, Binders, Flavoring agents & sweeteners, Disintegrants, Emulsifying agents, and Others) By Formulation Type (Oral formulation, Topical formulation, Parenteral formulation, and Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the report

How are the major segments performing in the Biologic Excipients market?

In 2022, the organic segment accounted for the largest market share owing to the uniqueness of organic excipients that facilitate drug delivery.
In 2022, the oral formulations segment was anticipated to hold a prominent share in the global Biologic Excipients market as people typically prefer giving medications orally because it is convenient.
In 2022, the Polymer Excipients segment accounted for the largest market share because the pharmaceutical industries experienced increased demand for excipients.
In 2022, the Biopharmaceutical Manufacturers segment accounted for the largest market share owing to growing spending on developing novel drugs.
In 2022, Fillers & diluents segment accounted for the largest market share to aid in the production and stabilisation of pharmaceuticals, fillers are often added. A supplement’s fillers bind and stabilise it. They don’t change or affect how well the active pharmaceutical ingredient works. (API).

Which region dominated the Biologic Excipients market?

In 2022, the North American region was anticipated to hold a prominent share in the global Biologic Excipients market. This depends on various elements, including the presence of important players, an increase in drug research, and a sizable population base. The biologic excipients market in the United States is anticipated to expand quickly over the studied period due to the rising prevalence of chronic diseases like cancer and diabetes. Nearly 1.7 million new cases of cancer were diagnosed in 2021, according to the National Cancer Institute, and more cases are anticipated in the coming years. Due to the increased demand for biological pharmaceuticals, this scenario benefits the industry’s expansion. Furthermore, the development of the industry will benefit from improved regulatory conditions. Regulatory agencies are developing.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

How US Market is Performing in the Biologic Excipients market?

In 2022, the U.S. held the largest market share in the North American region. Numerous elements, including important players, rising drug development, and a sizable population base, can be credited with the region’s growth. Collaborations between businesses in this region are being used to develop biopharmaceutical excipients. For instance, in February 2020, ReForm Biologics LLC and MilliporeSigma collaborated to commercialize the company’s proprietary excipients in biotherapeutic formulations. MilliporeSigma will finance R&D to advance drug development and market ReForm Biologics’ excipients.

How is the economy impacting the global Biologic Excipients’ growth?

The COVID-19 pandemic had a small negative impact on this market’s expansion in several ways. The pandemic directly impacted supply and demand, upsetting pharmaceutical products’ logistics and supply chains. This hampered the creation of new drugs and destroyed industries heavily relying on outsourcing. Initial chaos was caused throughout the entire pharmaceutical ecosystem. Additionally, new regulations had to be developed by regulatory agencies to guarantee the highest level of patient safety after drug administration. After the lockdowns ended, the pharmaceutical industry took off because of the high demand for drugs like Remdesivir and hydroxychloroquine, which demonstrated promising effectiveness against COVID-19. Economic shocks and recessions have little effect on pharmaceutical and biotech companies.

What is the competitive environment of the Biologic Excipients market?

Companies in the biologic excipients market seek to improve their competitiveness through partnerships and acquisitions of established and up-and-coming market players. The producers have been pressuring regional drug producers to produce excipients in large quantities at nearby facilities and provide them to producers of biological drugs at extremely attractive prices. In January 2019, DuPont recently made additional investments in the development of FM1000, a specialized excipient that has the potential to double the shelf life of surfactants.

Executive Summary

What are the key trends in the Biologic Excipients market?

Pharmaceuticals and clinical pharmacy practise are undergoing a paradigm shift as a result of three-dimensional (3D) printing, moving away from the traditional mass production of drugs and towards individualized, tailored drug products. By enabling the on-demand design and production of flexible formulations with customised dosages, shapes, sizes, drug release, and multi-drug combinations, the concept has the potential to benefit patients, pharmacists, and the pharmaceutical industry alike. This marks a turning point in the history of 3D printing technology in the pharmaceutical industry, necessitating the participation and support of healthcare professionals, including pharmacists, doctors, nurses, and pharmacy technicians, among others, in order to facilitate the widespread adoption of the technology in clinical practise.
The pharmaceutical industry has had to stay on its toes due to the FDA’s requirement for drug approval. Industry experts have emphasized adhering to best practices when producing drugs.

How is Growing Demand for Biosimilars Fuelling the Biologic Excipients Market?

The development of generic drugs is becoming increasingly popular, boosting the market for biological excipients. Generic medications are replicas of brand-name medications sold on the market for less money. More than 80% of prescriptions filled in the United States are for these medications, which offer the same dosage, strength, and quality. Given the increased demand for biological excipients in producing generic drugs, this scenario is advantageous for expanding the biologic excipients industry. Additionally, Asia’s high disease prevalence predicts a surge in generic drug demand. For instance, the Indian population primarily uses generic medications because they are inexpensive and have demonstrated the greatest effectiveness in treating chronic diseases, which has increased the demand for biologic excipients.

Which are the key investments by the Biologic Excipients market players?

The demand for novel excipients will rise as investments in biologics, and advanced dosage forms develop. DuPont has recently made additional investments in the development of a specialized excipient called FM1000 invest that has the potential to double the shelf life of surfactants. Roquette had previously progressed by increasing investments in the creation of specialized excipients. The revenue index of the global biologic excipients market will rise due to such developments among participating pharmaceutical companies.

Some major players in the Biologic Excipients market are B. Braun Melsungen AG, Medline Industries, Inc., Stryker Corporation, Ackermann Instrumente GmbH, ASFS Medic’s company, Medino GmbH, Peters Surgical, Medtronic, Mediflex Surgical Products and Grena LTD, and others.

What are the Major Driving Factors for the Biologic Excipients Market?

Excipients are crucial in biopharmaceuticals because they facilitate effective ingredient binding, alter the solubility and bioavailability of API, and improve drug stability in the dosage form. Owing to lower manufacturing costs and enhancing the patient experience, it is crucial to choose the appropriate excipient. Multi-functional biopharmaceutical excipients are also becoming more and more popular, which is fueling the market’s expansion. They are successful and efficient in enhancing the production of biopharmaceuticals. Some benefits include reduced operating costs, increased productivity, and improved product quality. The success of COVID-19 vaccines largely depends on their efficacy, which can be increased using effective drug delivery systems. This presents enormously lucrative opportunities for market entities.

What are the Major Risks for the Biologic Excipients Market?

Although many factors are driving the market for biologic excipients, improper data documentation regarding the GRAS status of excipients, regulatory audits that limit supply capacity, regulatory barriers that prevent the development of novel excipients, and stability testing of excipients that imposes financial obligations on drug manufacturers will restrain market growth over the forecast period.

Which is the key formulation Type in the Biologic Excipients market?

The oral formulations segment is expected to hold a prominent share in the global Biologic Excipients market during the forecast period. The increase can be attributed to the fact that oral formulations typically require more excipients than other dosage forms during the drug development process, and it is being encouraged by the adoption of a more patient-centric approach by drug manufacturers. According to a survey, approximately 90% of the formulations on the market are solid tablets. Industry participants have concentrated on integrating technology to simplify the production of oral formulations of higher quality. Furthermore, because it is convenient, people typically prefer giving medications orally. Additionally, a pharmacogenetics study suggests that the efficacy of oral formulations is noticeably higher than that of topical formulations, which supports the market’s growth.

How is the Biologic Excipients market performing in regions?

Due to the existence of significant CMOs engaged in drug development, the Asia Pacific market is anticipated to experience the fastest growth rate during the forecast period. The development of biosimilars is largely being carried out in this region by nations like China, India, and South Korea. There are a number of factors driving the extensive development of biosimilars, including cost-effectiveness, a supportive regulatory environment, a large population base, and affordability. Biopharmaceutical excipients are thus needed for the creation of biosimilars in order to guarantee drug stability.

What is the regulatory landscape for the Biologic Excipients market?

Diverse tasks are needed for effective drug regulation. Monitoring adverse drug reactions for investigational and marketed drugs, evaluating safety and efficacy data from animal and clinical trials, licensing and inspecting manufacturing facilities and distribution channels to ensure that drugs are not contaminated, and quality control of drug promotion and advertising to ensure that safety and efficacy claims are accurate are all important tasks. In some nations, a single agency oversees all aspects of drug regulation. In some other countries, particularly those with a federal system of government, state or provincial governments are in charge of some aspects of drug regulation.

What is the Market Size of Biologic Excipients regarding value?

The global Biologic Excipients market is anticipated to grow at a substantial CAGR of 3.1% in the upcoming years. The global Biologic Excipients industry was estimated to be worth USD 1.2 billion in 2022 and is expected to be USD 1.48 billion by 2030.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the major players planning for the future of the Biologic Excipients market?

Since it increases drug stability, API solubility, pharmacological activity, and pharmacological activity with targeted delivery, nanotechnology has been used increasingly in the pharmaceutical industry over the past few years. With the advent of such technologies, pharmaceutical companies are now concentrating on creating new methods that improve the functionality of excipients.

REPORT ATTRIBUTE	DETAILS
Biologic Excipients Market by Volume	Yes
Biologic Excipients Market by Value	Yes
Biologic Excipients Market, Tornado Analysis	Yes
Biologic Excipients Market, STAR Analysis	Yes
Biologic Excipients Market, SRC Analysis	Yes
Biologic Excipients Market, Import-Export Data	Yes (On Demand)
Biologic Excipients Market Pricing Analysis	Yes (On Demand)
Biologic Excipients Market Segment Analysis	By Product Type (Organic, Inorganic, and Others) By Excipient Type (Polymers, Sugar Alcohols, Polysorbates, Inorganic Salts, Amino Acids, Surfactants, and Others) By Functionality (Fillers & diluents, Suspending & viscosity agents, Coating agents, Binders, Flavoring agents & sweeteners, Disintegrants, Emulsifying agents, and Others) By Formulation Type (Oral formulation, Topical formulation, Parenteral formulation, and Others) By End Users (Biopharmaceutical Manufacturers, Contract Research Organizations, Contract Manufacturing Organizations, and Research Organizations)
Biologic Excipients Market, Regional Analysis	North America (US and Canada) Europe (Germany, UK, France, Italy, Spain, and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and Rest of the Middle East and Africa)
Biologic Excipients Market Key Companies	B. Braun Melsungen AG, Medline Industries, Inc., Stryker Corporation, Ackermann Instrumente GmbH, ASFS Medic’s company, Medino GmbH, Peters Surgical, Medtronic, Mediflex Surgical Products and Grena LTD, and others.
Biologic Excipients Market Competitive Landscape	Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted

Segmentation of Global Biologic Excipients Market-

Global Biologic Excipients Market – By Product Type

Organic
Inorganic
Others

Global Biologic Excipients Market – By Excipient Type

Polymers
Sugar Alcohols
Polysorbates
Inorganic Salts
Amino Acids
Surfactants
Others

Global Biologic Excipients Market – By Functionality

Fillers & diluents
Suspending & viscosity agents
Coating agents
Binders
Flavoring agents & sweeteners
Disintegrants
Emulsifying agents
Others

Global Biologic Excipients Market – By Formulation Type

Oral formulation
Topical formulation
Parenteral formulation
Others

Global Biologic Excipients Market – By End Users

Biopharmaceutical Manufacturers
Contract Research Organizations
Contract Manufacturing Organizations
Research Organizations

Global Biologic Excipients Market – By Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Biologic Excipients Market
2.2. Global Biologic Excipients Market, By Product Type
2.3. Global Biologic Excipients Market, By Excipient Type
2.4. Global Biologic Excipients Market, By Functionality
2.5. Global Biologic Excipients Market, By Formulation Type
2.6. Global Biologic Excipients Market, By End User
2.7. Global Biologic Excipients Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Biologic Excipients Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product Type
3.5.2. Excipient Type
3.5.3. Functionality
3.5.4. Formulation Type
3.5.5. End User
3.5.6. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Biologic Excipients Market
7.1. Global Biologic Excipients Market, by Product Type, 2017-2030(US$ Bn)
7.1.1. Overview
7.1.2. Global Biologic Excipients Market, By Product Type, 2022 vs 2030 (in%)
7.1.3. Global Biologic Excipients Market, By Organic, 2017-2030 (US$ Bn)
7.1.4. Global Biologic Excipients Market, By Inorganic, 2017-2030 (US$ Bn)
7.1.5. Global Biologic Excipients Market, By Others, 2017-2030 (US$ Bn)
7.2. Global Biologic Excipients Market, by Excipient Type, 2017-2030(US$ Bn)
7.2.1. Overview
7.2.2. Global Biologic Excipients Market, By Excipient Type, 2022 vs 2030 (in%)
7.2.3. Global Biologic Excipients Market, By Polymers, 2017-2030 (US$ Bn)
7.2.4. Global Biologic Excipients Market, By Sugar Alcohols, 2017-2030 (US$ Bn)
7.2.5. Global Biologic Excipients Market, By Polysorbates, 2017-2030 (US$ Bn)
7.2.6. Global Biologic Excipients Market, By Inorganic Salts, 2017-2030 (US$ Bn)
7.2.7. Global Biologic Excipients Market, By Amino Acids, 2017-2030 (US$ Bn)
7.2.8. Global Biologic Excipients Market, By Surfactants, 2017-2030 (US$ Bn)
7.2.9. Global Biologic Excipients Market, By Others, 2017-2030 (US$ Bn)
7.3. Global Biologic Excipients Market, by Functionality, 2017-2030(US$ Bn)
7.3.1. Overview
7.3.2. Global Biologic Excipients Market, By Functionality, 2022 vs 2030 (in%)
7.3.3. Global Biologic Excipients Market, By Fillers & diluents, 2017-2030 (US$ Bn)
7.3.4. Global Biologic Excipients Market, By Suspending & viscosity agents, 2017-2030 (US$ Bn)
7.3.5. Global Biologic Excipients Market, By Coating agents, 2017-2030 (US$ Bn)
7.3.6. Global Biologic Excipients Market, By Binders, 2017-2030 (US$ Bn)
7.3.7. Global Biologic Excipients Market, By Flavoring agents & sweeteners, 2017-2030 (US$ Bn)
7.3.8. Global Biologic Excipients Market, By Disintegrants, 2017-2030 (US$ Bn)
7.3.9. Global Biologic Excipients Market, By Emulsifying agents, 2017-2030 (US$ Bn)
7.3.10. Global Biologic Excipients Market, By Others, 2017-2030 (US$ Bn)
7.4. Global Biologic Excipients Market, by Formulation Type, 2017-2030(US$ Bn)
7.4.1. Overview
7.4.2. Global Biologic Excipients Market, By Formulation Type, 2022 vs 2030 (in%)
7.4.3. Global Biologic Excipients Market, By Oral formulation, 2017-2030 (US$ Bn)
7.4.4. Global Biologic Excipients Market, By Topical formulation, 2017-2030 (US$ Bn)
7.4.5. Global Biologic Excipients Market, By Parenteral formulation, 2017-2030 (US$ Bn)
7.4.6. Global Biologic Excipients Market, By Others, 2017-2030 (US$ Bn)
7.5. Global Biologic Excipients Market, by End User, 2017-2030(US$ Bn)
7.5.1. Overview
7.5.2. Global Biologic Excipients Market, By End User, 2022 vs 2030 (in%)
7.5.3. Global Biologic Excipients Market, By Biopharmaceutical Manufacturers, 2017-2030 (US$ Bn)
7.5.4. Global Biologic Excipients Market, By Contract Research Organizations, 2017-2030 (US$ Bn)
7.5.5. Global Biologic Excipients Market, By Contract Manufacturing Organizations, 2017-2030 (US$ Bn)
7.5.6. Global Biologic Excipients Market, By Research Organizations, 2017-2030 (US$ Bn)

8. North America Biologic Excipients Market Analysis
8.1. North America Biologic Excipients Market, by Product Type, 2017-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Biologic Excipients Market, by Excipient Type, 2017-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Biologic Excipients Market, by Functionality, 2017-2030(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Biologic Excipients Market, by Formulation Type, 2017-2030(US$ Bn)
8.4.1. Overview
8.4.2. SRC Analysis
8.5. North America Biologic Excipients Market, by End User, 2017-2030(US$ Bn)
8.5.1. Overview
8.5.2. SRC Analysis
8.6. North America Biologic Excipients Market, by Country, 2017-2030 (US$ Bn)
8.6.1. U.S.
8.6.1.1. U.S. Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.6.1.2. U.S. Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
8.6.1.3. U.S. Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
8.6.1.4. U.S. Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
8.6.1.5. U.S. Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
8.6.1.6. U.S. Biologic Excipients, By End User, 2017-2030 (US$ Bn)
8.6.2. Canada
8.6.2.1. Canada Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.6.2.2. Canada Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
8.6.2.3. Canada Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
8.6.2.4. Canada Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
8.6.2.5. Canada Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
8.6.2.6. Canada Biologic Excipients, By End User, 2017-2030 (US$ Bn)

9. Europe Biologic Excipients Market Analysis
9.1. Europe Biologic Excipients Market, by Product Type, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Biologic Excipients Market, by Excipient Type, 2017-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Biologic Excipients Market, by Functionality, 2017-2030(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Biologic Excipients Market, by Formulation Type, 2017-2030(US$ Bn)
9.4.1. Overview
9.4.2. SRC Analysis
9.5. Europe Biologic Excipients Market, by End User, 2017-2030(US$ Bn)
9.5.1. Overview
9.5.2. SRC Analysis
9.6. Europe Biologic Excipients Market, by Country, 2017-2030 (US$ Bn)
9.6.1. Germany
9.6.1.1. Germany Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.6.1.2. Germany Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
9.6.1.3. Germany Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
9.6.1.4. Germany Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
9.6.1.5. Germany Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
9.6.1.6. Germany Biologic Excipients, By End User, 2017-2030 (US$ Bn)
9.6.2. France
9.6.2.1. France Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.6.2.2. France Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
9.6.2.3. France Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
9.6.2.4. France Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
9.6.2.5. France Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
9.6.2.6. France Biologic Excipients, By End User, 2017-2030 (US$ Bn)
9.6.3. UK
9.6.3.1. UK Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.6.3.2. UK Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
9.6.3.3. UK Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
9.6.3.4. UK Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
9.6.3.5. UK Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
9.6.3.6. UK Biologic Excipients, By End User, 2017-2030 (US$ Bn)
9.6.4. Italy
9.6.4.1. Italy Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.6.4.2. Italy Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
9.6.4.3. Italy Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
9.6.4.4. Italy Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
9.6.4.5. Italy Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
9.6.4.6. Italy Biologic Excipients, By End User, 2017-2030 (US$ Bn)
9.6.5. Spain
9.6.5.1. Spain Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.6.5.2. Spain Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
9.6.5.3. Spain Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
9.6.5.4. Spain Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
9.6.5.5. Spain Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
9.6.5.6. Spain Biologic Excipients, By End User, 2017-2030 (US$ Bn)
9.6.6. Rest of Europe
9.6.6.1. Rest of Europe Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.6.6.2. Rest of Europe Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
9.6.6.3. Rest of Europe Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
9.6.6.4. Rest of Europe Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
9.6.6.5. Rest of Europe Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
9.6.6.6. Rest of Europe Biologic Excipients, By End User, 2017-2030 (US$ Bn)

10. Asia Pacific Biologic Excipients Market Analysis
10.1. Asia Pacific Biologic Excipients Market, by Product Type, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Biologic Excipients Market, by Excipient Type, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Biologic Excipients Market, by Functionality, 2017-2030(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Biologic Excipients Market, by Formulation Type, 2017-2030(US$ Bn)
10.4.1. Overview
10.4.2. SRC Analysis
10.5. Asia Pacific Biologic Excipients Market, by End User, 2017-2030(US$ Bn)
10.5.1. Overview
10.5.2. SRC Analysis
10.6. Asia Pacific Biologic Excipients Market, by Country, 2017-2030 (US$ Bn)
10.6.1. China
10.6.1.1. China Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.6.1.2. China Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
10.6.1.3. China Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
10.6.1.4. China Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
10.6.1.5. China Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
10.6.1.6. China Biologic Excipients, By End User, 2017-2030 (US$ Bn)
10.6.2. Japan
10.6.2.1. Japan Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.6.2.2. Japan Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
10.6.2.3. Japan Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
10.6.2.4. Japan Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
10.6.2.5. Japan Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
10.6.2.6. Japan Biologic Excipients, By End User, 2017-2030 (US$ Bn)
10.6.3. India
10.6.3.1. India Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.6.3.2. India Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
10.6.3.3. India Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
10.6.3.4. India Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
10.6.3.5. India Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
10.6.3.6. India Biologic Excipients, By End User, 2017-2030 (US$ Bn)
10.6.4. South Korea
10.6.4.1. South Korea Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.6.4.2. South Korea Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
10.6.4.3. South Korea Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
10.6.4.4. South Korea Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
10.6.4.5. South Korea Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
10.6.4.6. South Korea Biologic Excipients, By End User, 2017-2030 (US$ Bn)
10.6.5. South-East Asia
10.6.5.1. South-East Asia Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.6.5.2. South-East Asia Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
10.6.5.3. South-East Asia Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
10.6.5.4. South-East Asia Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
10.6.5.5. South-East Asia Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
10.6.5.6. South-East Asia Biologic Excipients, By End User, 2017-2030 (US$ Bn)
10.6.6. Rest of Asia Pacific
10.6.6.1. Rest of Asia Pacific Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.6.6.2. Rest of Asia Pacific Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
10.6.6.3. Rest of Asia Pacific Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
10.6.6.4. Rest of Asia Pacific Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
10.6.6.5. Rest of Asia Pacific Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
10.6.6.6. Rest of Asia Pacific Biologic Excipients, By End User, 2017-2030 (US$ Bn)

11. Latin America Biologic Excipients Market Analysis
11.1. Latin America Biologic Excipients Market, by Product Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Biologic Excipients Market, by Excipient Type, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Biologic Excipients Market, by Functionality, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Biologic Excipients Market, by Formulation Type, 2017-2030(US$ Bn)
11.4.1. Overview
11.4.2. SRC Analysis
11.5. Latin America Biologic Excipients Market, by End User, 2017-2030(US$ Bn)
11.5.1. Overview
11.5.2. SRC Analysis
11.6. Latin America Biologic Excipients Market, by Country, 2017-2030 (US$ Bn)
11.6.1. Brazil
11.6.1.1. Brazil Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.6.1.2. Brazil Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
11.6.1.3. Brazil Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
11.6.1.4. Brazil Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
11.6.1.5. Brazil Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
11.6.1.6. Brazil Biologic Excipients, By End User, 2017-2030 (US$ Bn)
11.6.2. Mexico
11.6.2.1. Mexico Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.6.2.2. Mexico Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
11.6.2.3. Mexico Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
11.6.2.4. Mexico Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
11.6.2.5. Mexico Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
11.6.2.6. Mexico Biologic Excipients, By End User, 2017-2030 (US$ Bn)
11.6.3. Rest of Latin America
11.6.3.1. Rest of Latin America Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.6.3.2. Rest of Latin America Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
11.6.3.3. Rest of Latin America Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
11.6.3.4. Rest of Latin America Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
11.6.3.5. Rest of Latin America Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
11.6.3.6. Rest of Latin America Biologic Excipients, By End User, 2017-2030 (US$ Bn)

12. Middle East and Africa Biologic Excipients Market Analysis
12.1. Middle East and Africa Biologic Excipients Market, by Product Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Biologic Excipients Market, by Excipient Type, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Biologic Excipients Market, by Functionality, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Biologic Excipients Market, by Formulation Type, 2017-2030(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. Middle East and Africa Biologic Excipients Market, by End User, 2017-2030(US$ Bn)
12.5.1. Overview
12.5.2. SRC Analysis
12.6. Middle East and Africa Biologic Excipients Market, by Country, 2017-2030 (US$ Bn)
12.6.1. GCC Countries
12.6.1.1. GCC Countries Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.6.1.2. GCC Countries Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
12.6.1.3. GCC Countries Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
12.6.1.4. GCC Countries Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
12.6.1.5. GCC Countries Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
12.6.1.6. GCC Countries Biologic Excipients, By End User, 2017-2030 (US$ Bn)
12.6.2. South Africa
12.6.2.1. South Africa Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.6.2.2. South Africa Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
12.6.2.3. South Africa Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
12.6.2.4. South Africa Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
12.6.2.5. South Africa Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
12.6.2.6. South Africa Biologic Excipients, By End User, 2017-2030 (US$ Bn)
12.6.3. Rest of Middle East and Africa
12.6.3.1. Rest of Middle East and Africa Biologic Excipients Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.6.3.2. Rest of Middle East and Africa Biologic Excipients, By Product Type, 2017-2030 (US$ Bn)
12.6.3.3. Rest of Middle East and Africa Biologic Excipients, By Excipient Type, 2017-2030 (US$ Bn)
12.6.3.4. Rest of Middle East and Africa Biologic Excipients, By Functionality, 2017-2030 (US$ Bn)
12.6.3.5. Rest of Middle East and Africa Biologic Excipients, By Formulation Type, 2017-2030 (US$ Bn)
12.6.3.6. Rest of Middle East and Africa Biologic Excipients, By End User, 2017-2030 (US$ Bn)

13. Company Profiles
13.1. B. Braun Melsungen AG
13.1.1. Company Overview
13.1.2. Products/Others Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Medline Industries, Inc.
13.3. Stryker Corporation
13.4. Ackermann Instrumente GmbH
13.5. ASFS Medic’s company
13.6. Medino GmbH
13.7. Peters Surgical
13.8. Medtronic
13.9. Mediflex Surgical Products
13.10. Grena LTD
13.11. Others

List of Figures
FIG. 1 Global Biologic Excipients Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Biologic Excipients Market Segmentation
FIG. 4 Global Biologic Excipients Market, by Product Type, 2022 (US$ Bn)
FIG. 5 Global Biologic Excipients Market, by Excipient Type, 2022 (US$ Bn)
FIG. 6 Global Biologic Excipients Market, by Functionality Type, 2022 (US$ Bn)
FIG. 7 Global Biologic Excipients Market, by Formulation Type, 2022 (US$ Bn)
FIG. 8 Global Biologic Excipients Market, by End User, 2022 (US$ Bn)
FIG. 9 Global Biologic Excipients Market, by Geography, 2022 (US$ Bn)
FIG. 10 Attractive Investment Proposition, by Product Type, 2022
FIG. 11 Attractive Investment Proposition, by Excipient Type, 2022
FIG. 12 Attractive Investment Proposition, by Functionality Type, 2022
FIG. 13 Attractive Investment Proposition, by Formulation Type, 2022
FIG. 14 Attractive Investment Proposition, by End User, 2022
FIG. 15 Attractive Investment Proposition, by Geography, 2022
FIG. 16 Global Market Share Analysis of Key Biologic Excipients Market Manufacturers, 2022
FIG. 17 Global Market Positioning of Key Biologic Excipients Market Manufacturers, 2022
FIG. 18 Global Biologic Excipients Market Value Contribution, By Product Type, 2022 & 2030 (Value %)
FIG. 19 Global Biologic Excipients Market, by Organic, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Biologic Excipients Market, by Solution, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Biologic Excipients Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 22 Global Biologic Excipients Market Value Contribution, By Excipient Type, 2022 & 2030 (Value %)
FIG. 23 Global Biologic Excipients Market, by Polymers, Value, 2017-2030 (US$ Bn)
FIG. 24 Global Biologic Excipients Market, by Sugar Alcohols, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Biologic Excipients Market, by Polysorbates, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Biologic Excipients Market, by Inorganic Salts, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Biologic Excipients Market, by Amino Acids, Value, 2017-2030 (US$ Bn)
FIG. 28 Global Biologic Excipients Market, by Surfactants, Value, 2017-2030 (US$ Bn)
FIG. 29 Global Biologic Excipients Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 30 Global Biologic Excipients Market Value Contribution, By Functionality, 2022 & 2030 (Value %)
FIG. 31 Global Biologic Excipients Market, by Fillers & diluents, Value, 2017-2030 (US$ Bn)
FIG. 32 Global Biologic Excipients Market, by Suspending & viscosity agents, Value, 2017-2030 (US$ Bn)
FIG. 33 Global Biologic Excipients Market, by Coating agents, Value, 2017-2030 (US$ Bn)
FIG. 34 Global Biologic Excipients Market, by Binders, Value, 2017-2030 (US$ Bn)
FIG. 35 Global Biologic Excipients Market, by Flavoring agents & sweeteners, Value, 2017-2030 (US$ Bn)
FIG. 36 Global Biologic Excipients Market, by Disintegrants, Value, 2017-2030 (US$ Bn)
FIG. 37 Global Biologic Excipients Market, by Emulsifying agents, Value, 2017-2030 (US$ Bn)
FIG. 38 Global Biologic Excipients Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 39 Global Biologic Excipients Market Value Contribution, By Formulation Type, 2022 & 2030 (Value %)
FIG. 40 Global Biologic Excipients Market, by Oral formulation, Value, 2017-2030 (US$ Bn)
FIG. 41 Global Biologic Excipients Market, by Topical formulation, Value, 2017-2030 (US$ Bn)
FIG. 42 Global Biologic Excipients Market, by Parenteral formulation, Value, 2017-2030 (US$ Bn)
FIG. 43 Global Biologic Excipients Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 44 Global Biologic Excipients Market Value Contribution, By End User, 2022 & 2030 (Value %)
FIG. 45 Global Biologic Excipients Market, by Biopharmaceutical Manufacturers, Value, 2017-2030 (US$ Bn)
FIG. 46 Global Biologic Excipients Market, by Contract Research Organizations, Value, 2017-2030 (US$ Bn)
FIG. 47 Global Biologic Excipients Market, by Contract Manufacturing Organizations, Value, 2017-2030 (US$ Bn)
FIG. 48 Global Biologic Excipients Market, by Research Organizations, Value, 2017-2030 (US$ Bn)
FIG. 49 North America Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 50 U.S. Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 51 Canada Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 52 Europe Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 53 Germany Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 54 France Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 55 U.K. Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 56 Italy Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 57 Spain Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 58 Rest of Europe Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 59 Asia Pacific Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 60 China Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 61 Japan Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 62 India Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 63 South Korea Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 64 Southeast Asia Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 65 Rest of Asia Pacific Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 66 Latin America Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 67 Brazil Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 68 Mexico Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 69 Rest of Latin America Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 70 Middle East & Africa Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 71 GCC Countries Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 72 South Africa Biologic Excipients Market, 2017-2030 (US$ Bn)
FIG. 73 Rest of Middle East and Africa Biologic Excipients Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Biologic Excipients Market
TABLE 2 Global Biologic Excipients Market, by Competitive Benchmarking, 2022
TABLE 3 Global Biologic Excipients Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Biologic Excipients Market, by Key Strategies Analysis, 2022
TABLE 5 Global Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 6 Global Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 7 Global Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 8 Global Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 9 Global Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 10 Global Biologic Excipients Market, by Geography, 2017-2030 (US$ Bn)
TABLE 11 North America Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 12 North America Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 13 North America Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 14 North America Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 15 North America Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 16 North America Biologic Excipients Market, by Country, 2017-2030 (US$ Bn)
TABLE 17 US Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 18 US Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 19 US Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 20 US Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 21 US Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 22 Canada Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 23 Canada Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 24 Canada Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 25 Canada Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 26 Canada Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 27 Europe Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 28 Europe Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 29 Europe Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 30 Europe Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 31 Europe Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 32 Europe Biologic Excipients Market, by Country, 2017-2030 (US$ Bn)
TABLE 33 Germany Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 34 Germany Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 35 Germany Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 36 Germany Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 37 Germany Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 38 France Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 39 France Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 40 France Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 41 France Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 42 France Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 43 UK Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 44 UK Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 45 UK Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 46 UK Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 47 UK Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 48 Italy Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 49 Italy Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 50 Italy Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 51 Italy Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 52 Italy Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 53 Spain Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 54 Spain Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 55 Spain Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 56 Spain Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 57 Spain Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 58 Rest of Europe Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 59 Rest of Europe Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 60 Rest of Europe Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 61 Rest of Europe Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 62 Rest of Europe Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 63 Asia Pacific Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 64 Asia Pacific Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 65 Asia Pacific Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 66 Asia Pacific Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 67 Asia Pacific Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 68 Asia Pacific Biologic Excipients Market, by Country, 2017-2030 (US$ Bn)
TABLE 69 China Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 70 China Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 71 China Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 72 China Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 73 China Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 74 Japan Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 75 Japan Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 76 Japan Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 77 Japan Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 78 Japan Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 79 India Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 80 India Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 81 India Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 82 India Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 83 India Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 84 South Korea Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 85 South Korea Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 86 South Korea Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 87 South Korea Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 88 South Korea Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 89 South East Asia Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 90 South East Asia Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 91 South East Asia Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 92 South East Asia Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 93 South East Asia Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 94 Rest of Asia Pacific Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 95 Rest of Asia Pacific Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 96 Rest of Asia Pacific Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 97 Rest of Asia Pacific Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 98 Rest of Asia Pacific Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 99 Latin America Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 100 Latin America Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 101 Latin America Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 102 Latin America Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 103 Latin America Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 104 Latin America Biologic Excipients Market, by Country, 2017-2030 (US$ Bn)
TABLE 105 Brazil Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 106 Brazil Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 107 Brazil Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 108 Brazil Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 109 Brazil Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 110 Mexico Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 111 Mexico Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 112 Mexico Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 113 Mexico Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 114 Mexico Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 115 Rest of Latin America Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 116 Rest of Latin America Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 117 Rest of Latin America Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 118 Rest of Latin America Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 119 Rest of Latin America Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 120 Middle East and Africa Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 121 Middle East and Africa Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 122 Middle East and Africa Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 123 Middle East and Africa Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 124 Middle East and Africa Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 125 Middle East and Africa Biologic Excipients Market, by Country, 2017-2030 (US$ Bn)
TABLE 126 GCC Countries Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 127 GCC Countries Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 128 GCC Countries Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 129 GCC Countries Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 130 GCC Countries Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 131 South Africa Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 132 South Africa Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 133 South Africa Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 134 South Africa Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 135 South Africa Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)
TABLE 136 Rest of Middle East and Africa Biologic Excipients Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 137 Rest of Middle East and Africa Biologic Excipients Market, by Excipient Type, 2017-2030 (US$ Bn)
TABLE 138 Rest of Middle East and Africa Biologic Excipients Market, by Functionality, 2017-2030 (US$ Bn)
TABLE 139 Rest of Middle East and Africa Biologic Excipients Market, by Formulation Type, 2017-2030 (US$ Bn)
TABLE 140 Rest of Middle East and Africa Biologic Excipients Market, by End User, 2017-2030 (US$ Bn)

Frequently Asked Questions:

How does COVID-19 Impact the global Biologic Excipients market?

Following the pandemic outbreak, biopharmaceutical excipients are anticipated to become more popular due to the high demand for managing SARS-COV-2 infection and developing vaccines.

Which is the leading region of the market for Biologic Excipients?

North America accounted for the most heightened share in the global Biologic Excipients market.

What are the key drivers for the growth of the Biologic Excipients market?

The demand for extended-release or sustained-release formulations and the rising demand for biologic excipients are driving the growth of the market for biologic excipients.

Which is the major segment in the Biologic Excipients market by product type?

The organic segment had a major share in the global market in 2022.

Which is the major segment in the Biologic Excipients market by formulation type?

The Oral formulation segment had a major share in the global market.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –